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Abstract. Metastatic colonization of a secondary or-
gan site is initiated by the attachment of blood-borne
tumor cells to organ-specific adhesion molecules ex-
pressed on the surface of microvascular endothelial
cells. Using digital video imaging microscopy and flu-
orescence activated cell sorting techniques, we show
here that highly metastatic cells (B16-F10 murine mela-
noma and R3230AC-MET rat mammary adenocarcino-
ma cells) previously labeled with the fluorescent dye
BCECF begin to transfer dye to endothelial cell mono-
layers shortly after adhesion is established. The extent
of BCECF transfer to endothelial cell monolayers is
dependent upon the number of BCECF-labeled tumor
cells seeded onto the endothelial cell monolayer and
the time of coculture of the two cell types, as visualized
by an increase in the number of BCECF-positive cells
M
ETASTASIS is the colonization of selective, secon-
dary organ sites by dissemination of tumor cells
from their primary location. This event is depend-
ent upon distinct tumor and host cell characteristics and is
achieved in multiple, highly coordinated steps (1, 32, 35, 43,
44). Early steps in the metastatic cascade include the shed-
ding ofcancer cellsfrom the primary neoplasm, the invasion
of enzymatically and compositionally altered host extracel-
lular matrices, and the intravasation of tumor cells into
lymph and/or blood vessels (18, 27, 29, 34). Upon circula-
tion, many cancer cells are eradicated by physical forces ex-
erted onto them duringpassage through the microvasculature
of secondary organs (41, 42) and by host defence mecha-
nisms. The few surviving tumor cellsare thought to colonize
selective organ sites by recognizing organ-specific adhesion
molecules expressed on the surface of vascular endothelial
cells (1, 2, 4, 32, 33, 35, 37). The events that follow tumor
cell adhesion to the endothelium and lead to the establish-
ment of secondary tumor colonies are poorly understood.
A widely supported hypothesis is that upon tumor cell
adhesion to endothelium a retraction of the endothelial cell
occurs which exposes its basement membrane to the arrested
tumor cell (21-23, 40). Numerous studies have shown that
tumor cells equipped with specific ligands recognize and
bind to components in the vascular basement membrane
(26), thereby initiating extravasation and the beginning of
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among cells stained with an endothelial cell-specific
mAb. Dye transfer to BAEC monolayers proceeds with
a progressive loss of fluorescence intensity in the
BCECF-labeled tumor cell population with time of co-
culture. The transfer of dye is bidirectional and sensi-
tive to inhibition by 1-heptanol. In contrast, poorly
metastatic B16-FO melanoma cells and non-metastatic
R3230AC-LR mammary adenocarcinoma cells do not
efficiently couple with vascular endothelial cells. It is
inferred from these experiments and from the amounts
of connexin43 mRNA expressed by tumor cells that
tumor cell/endothelial cell communication is mediated
by gap junctional channels and that this interaction
may play a critical role in tumor cell extravasation at
secondary sites.
new growth at secondary organ sites. In studying the organ-
specific arrest of cancer cells at secondary organ sites, we
have recently observed that highly metastatic tumor cells
upon adhering to the vascular endothelium establish cyto-
plasmic conduits with endothelial cells. Using digital video
imaging microscopy and timed fluorescence activated cell
sorting (FACS, a registered trademark of Becton Dickin-
son Co., Mountain View, CA), we show here that highly
metastatic tumor cellstransfer cytoplasmic dye via gap junc-
tion-like channels to endothelial cells. Dye transfer is sig-
nificantly diminished by an inhibitor of gap junction-me-
diated communication and in poorly metastatic tumor cells.
Materials and Methods
Materials
DME, Rosewell Park Memorial Institute-1640 medium (RPMI-1640),
and magnesium- and calcium-free HBSS were purchased from Gibco
Laboratories, (Grand Island, NY); FBS from Hyclone Laboratories, Inc.
(Logan, UT); 2;7'-bis(carboxylethyl)-5(and-6)carboxyfluorescein acetoxy-
methyl ester (BCECFAM) and the acid form (BCECF) from Molecular
Probes (Eugene, OR). Biotinylated goatanti-mouse IgG F(ab)z and phyco-
1. Abbreviations used in this paper: BCECFAM, 2',T-bis(Carboxylethyl)-
5(and-6)carboxyfluorescein acetoxymethyl ester; PE, phycoerythrin; RPMI-
1640, Rosewell Park Memorial Institute-1640.erythrin-avidin conjugate were from Accurate Chemical and Scientific
Corp. (Westbury, NY), respectively; and Falcon 35-mm tissue culture
dishes from Becton-Dickinson (Oxnard, CA). All other reagents were of
the highest grade available from Sigma Chemical Co. (St. Louis, MO).
CellCultures
Bovine aortic endothelial cells (BAEC) were isolated from thoracic aortas
of 18-mo-old steers, essentially as described by Booyse et al. (6). BAEC
weregrown and maintained inDME supplemented with 2-mM L-glutamine
and 10% heat-inactivated FBS. Aliquots of BAEC were frozen at passage
2 and used between passages 4 and 6. BAEC were selected for this study
over lung-derived capillary endothelial cells for the following reasons: (a)
the ease of isolating and maintaining primary BAEC cultures (6); (b) the
consistency ofgrowth and relative phenotypic stability ofcultured, primary
BAEC (3,33); and (c) the strong adherence of metastatic tumor cells to
BAEC monolayers (20,35). Since capillary endothelial cells, like BAEC, do
not represent endothelia of the primary, postcapillary extravasation site of
malignant tumorcells (45) and are often difficult to grow as phenotypically
stable cells (33), they are a clearly less desirable cell system for the present
studies.
The tumor cells selected for our studies were B16 murine melanoma cell
variants (12) obtained from D.1. J. Fidler (University of Texas System Can-
cer Center, M.D. Anderson Hospital and Tumor Institute, Houston, Texas)
and R3230AC rat mammary carcinoma cell variants (31) obtained from Dr.
J. A. Kellen (Sunnybrook Medical Center, University of Toronto, Toronto,
Canada). Both B16-FIO and R3230AC-MET were selected for high lung
colonization from their respectiveparental cell lines, while B16-PO (paren-
tal cell line) were low lung-metastatic and R3230AC-LR (WGA- and Con
A-resistant variant of R3230AC) were non-metastatic (12,31). Tumor cells
were maintained in RPMI-1640 supplemented with 10% FBS. MDCK cells
served as controls for BAEC, since they are deficient in intercellular com-
munication under conditions of high cell density (36). MDCK cells were
cultured and maintained according to the instructions of the distributor
(American Type Culture Collection, Rockville, MD) .
BCECFLabeling ofCells
Tumor cells were labeled with the membrane permeable, pH-sensitive dye
BCECF-AM (668 kD). Labeling was achieved with 1.5 ;.M BCECF-AM
in RPMI-1640, pH 7.4, for 30 min at 37°C in 5% C02 air essentially as
described by Guinanet al. (16). Upon entry ofthe dye intothe cell, intracel-
lular esterases rapidly cleaved the molecule to the fluorescent, membrane
impermeable acid form (BCECF: 520 kD). Labeled cells were washed
twice with serum-free medium, incubated in complete growth medium for
30 min at 37°C to allow any non-deesterified dye to leave the cells, washed
again, and used immediately indyetransferexperiments. The same labeling
procedures were employed for BAEC to study bidirectional transfer of
BCECF and for MDCK substituting for BAEC in control experiments.
Fluorescence andDigital Video ImagingMicroscopy
Confluent endothelial cell monolayers were cocultured for various periods
of time at 37°C with tumor cells that had been labeled with BCECF Un-
bound tumor cells were removed by washing with serum-free medium.
BAEC monolayers and adherenttumor cellswerefixed in situ in 1% formal-
dehyde in PBS and observed under a phase contrast or fluorescence micro-
scope. BCECF fluorescence was imaged with aNikon Diaphot invertednu-
croscope using a Nikon 40x objective lens (Nikon Inc., Garden City, NJ) .
Illumination at490 nm was accomplished with a 150 W Xenon source. Im-
ages were acquired with a microchannel plate image intensifier (model KS-
1380; Video Scope Intl. OPELCO, Washington, DC), coupled to a silicon
diode video camera (model 70; Dage-MTI Inc., Wabash, MI), digitized,
and averaged in a Tracor-Northem TN-8500 image processor and trans-
ferred to a hard disk. Background image from a different area (nonfluores-
cent) was collected and subtracted from each image.
FACSAnalyses ofBCECF Transfer
Confluent BAEC monolayers grownin 35-mmpetri disheswere seededwith
BCECF-labeled tumor cells and cocultured for various periods of time at
37°C. After having removed unbound tumor cells by washing with serum-
free medium, endothelial cells, andadherenttumorcells werereleasedfrom
the growth surfacewith 0.05 % trypsin and 0.02% EDTA in HBSS. The cell
suspension was washed twice with DME and incubated for 20 min at 4°C
with mAb directed againstan endothelial cell-specific surface epitope (45).
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The cells were washed four times with DME and incubated with the bi-
otirrylated F(ay)2 portion of the secondary antibody (goat anti-mouse
IgG). After an incubation period of 20 min at 4°C, cells were washed and
phycoerythrin-avidin conjugate added for 10 min. The cells were thor-
oughly washed with PBS, fixed in 1% formaldehyde in PBS, and examined
for both fluorescenn (BCECF) and phycoerythrin (PE) fluorescence in a
fluorescence activated cell sorter (Coulter Epics Profile; Coulter Elec-
tronics, Hialeah, FL) . Results were plotted as log BCECF fluorescence vs
log PE fluorescence. Inhibition ofcommunication betweentumor cells and
endothelial cells was studied in thepresenceof 3.5 mM 1-heptanol. Bidirec-
tional dye transfer was investigated using cocultures ofBCECF labeled en-
dothelial cell monolayers and unlabeled tumor cells. Control experiments
were conducted with MDCK cells as a communication-deficient replace-
ment for endothelial cells. Also, control experiments were performed to
verify that the secondary antibody as well as the PE-avidin did not label
cells in the absence ofthe primary antibody. Histogram printouts from the
FACS analyses were graphically represented for enhanced appearance.
Northern BlotAnalyses
Total cellular RNA was isolated from B16 melanoma cells (FO and F10) ac-
cording to the method ofChomczynski and Sacchi (9). RNA samples were
denatured with formaldehyde and subjected to 1% agarose/formaldehyde
gel electrophoresis. Separated RNA was transferred onto Hybond mem-
branes (Amersham Corp., Arlington Heights, IL) and cross-linked onto the
membranes by exposure to a300-run UV source for 2 min. High stringency
blots were prehybridized at 65°C for 4 h in 0.5 M phosphate buffer, pH 7.4,
1% BSA, and 7ßb SDS and then hybridized in the same buffer containing
10% formamide at 65°C for 24-48 h with connexin43 cDNA probe ob-
tained from Dr. D. Shalloway, Cornell University, Ithaca, NY. This probe
is the Pmll-Sell fragment excised from the dol43 plasmid, which was pre-
pared from lasmid p43 (5) . It was purified by gel electrophoresis and la-
beled with 3 [P]dCTP by random primer extension using the Klenow frag-
ment of DNA polymerase I and hexonucleotide primers (11). Unbound
probewas removed by three 10-min washes with 1XSSC/0.1% SDS at room
temperature, followed by a 15-20-min wash with O.1XSSC/0.1% SDS at
65°C. Hybridized mRNA species were identified by sutoradiography, and
relative amounts of mRNA estimated by computer assisted video scanning
(Bioimage Visage 110; Millipore Corp., Ann Arbor, MI) after verifying
equivalence ofloading (10 kg per lane, estimated as the 280/260-nm absor-
bance ratio) by scanning of ethidium bromide stained rRNA. Northern blot
analyses were repeated at least twice.
Results
BCECF Uptake and CellMorphology
Monolayers of BAEC, MDCK cells, B16 melanoma cells,
and R3230AC carcinoma cellsreadily tookup the membrane
permeable dye BCECF-AM and processed it in their cyto-
plasms to the membrane permeable fluorescent acid form.
BCECF had no adverse effect on cell morphology, growth,
and survival. BCECF-labeled BAEC and MDCK monolayers
exhibited a significantly lower fluorescence intensity than
B16 melanoma cells and R3230AC mammary carcinoma
cells. BAEC and MDCKcellsusually displayed a pale green-
ish fluorescence, whiletumor cells emitted an intense green/
yellow fluorescence. This difference in the extent ofBCECF
labeling of various cell types can be attributed to many fac-
tors including differences in BCECF-AM permeability rates,
amounts or activities of cytoplasmic esterases, cytoplasmic
pH levels, as well as cell shape. During a 6-h culture period
cells maintained their original fluorescence intensity and
there was no fluorescent dye leakage into the extracellular
compartment and no fluorescent vesicles were observed to
be shed into the medium.
BCECFTansfer Visualized byLightMicroscopy
BCECF transfer from unlabeled B16 melanoma cells to en-
dothelial cells was visualized using epifluorescence micros-
1376Figure 1 . BAEC monolayer seeded with BCECF-labeled B16-F10 melanoma cells and cocultured for 3 h : endothelial cells form a confluent
monolayer to which brightly fluorescent tumor cells are attached . Dye transfer from a B16-F10 melanoma cell (T) to a BAEC is depicted
(E) . (A) Phase-contrast and fluorescence ; (B) fluorescence only ; (C and D) color-enhanced digital video images (pseudocolor map) of
BCECF transfer from a labeled B16-F10 melanoma cell to aBAEC (C) and lateral homotypic dye spread to neighboring BAEC (D) . Bar,
10 Am .
copy combined with digital video imaging techniques.
Transfer ofBCECF fluorescent dye from metastatic B16-F10
melanoma cells to unlabeled BAEC monolayer was evident
by the appearance of pale greenish fluorescent endothelial
cells next to brightly fluorescent, adherent tumor cells (Fig.
1, A and B) . In digitized, color-enhanced images, tumor
cells were readily identified as brightly colored spheres sit-
ting on top of the endothelial cell monolayer. Dye transfer
was generally limited to endothelial cells that were in direct
contact with the BCECF-labeled tumor cells . Endothelial
cell dye uptake was often depicted as a fluorescent area adja-
cent to one side of the tumor cell, outlining the confines of
the endothelial cell and confirming the previous observation
that tumor cells predominantly adhered to the marginal
zones of endothelial cells (Fig . 1 C) . This area of fluores-
cence was significantly weaker and was in a clearly different
focal plane than that of the tumor cell . Occasionally a sec-
ondary transfer of cytoplasmic dye to neighboring en-
El-Sabbanand Pauli Tumor Cell/Endothelial Cell Communication
dothelial cells that were not in inunediate contact with the
tumor cells was observed . Lateral dye transfer proceeded
without leakage into the culture medium and was reflective
in morphology ofthe typical cobble-stone appearance of the
endothelial cell monolayer (Fig . 1 D) . Such dye transfer to
neighboring endothelial cells was limited to three or four
cells .
FRCSAnalyses ofBCECF Transfer
BCECF-labeled B16 melanoma cells began to transfer fluo-
rescent dye to the cytoplasm of confluent, nonlabeledBAEC
monolayers shortly after adhesion was established . Within
the first 15 min of coculture BCECF-labeled B16-F10 mela-
noma cells seeded at a density of 4.5 x 105 cells onto con-
fluent BAEC monolayers in35-mm dishes transferred dye to
40% of the endothelial cells, compared to 50% at 60 min of
coculture (Table I) . Highly metastatic B16-F10 melanoma
1377Table 1. BCECF TransferfromB16-F10 Melanoma Cells
to BAEC Monolayers as a Function ofTime
BAEC monolayers grown to confluence in 35-mm petri dishes (4.5 x 105
cells) were seeded with 5.0 x 10 5 BCECF-labeled B16-F10 melanoma cells
and cocultured for the indicated times . Cells were released from the growth
surface and analyzed by flow cytometry .
' Mean t SD
cells transferred BCECF to three to five times as many
BAEC than an equal number of low metastatic, BCECF-
labeled B16-FO cells cocultured for the same length of time
with unlabeled BAEC (Fig . 2 ; and Table II) . Similar ob-
servations were made with the R3230AC mammary carci-
noma cell variants . BCECF-labeled, high lung metastatic
R3230AC-MET seeded in increasing numbers onto confluent
BAEC monolayers transferred dye to increasing numbers of
endothelial cells . In contrast, the non-metastatic R3230AC-
LR tumor cells were unable to transfer dye to BAEC at any
of the seeding concentrations tested (Fig. 3) . These data cor-
related with the abilities of these tumor cells to adhere to en-
dothelial cells and with their lung colony formation potential
when injected into syngeneic hosts .
Direct transfer of dye from the cytoplasm of tumor cells
to the cytoplasm ofBAEC was verified by the following ex-
periments : (a) BAEC were unable to take up the acid form
ofBCECF, even when added to BAEC at double the label-
ing concentration (3 1M), thus, making it impossible that
BCECF was taken up by endothelial cells from the media
into which dead, labeled tumor cells had released their cyto-
plasmic dye ; (b) BCECF fluorescence was detected in cells
stained with an endothelial cell-specific mAb after coculture
of BCECF-labeled B16 melanoma cells (or R3230AC-MET
carcinoma cells) with unlabeled BAEC monolayers (Figs. 2
and 3) ; (c) the average fluorescence intensity ofthe BCECF-
labeled B16melanoma cells decreased with time of coculture
withBAEC monolayers, while the percent ofBAEC to which
BCECF was transferred increased (Table I) ; (d) The addition
of increasing numbers of BCECF-labeled, metastatic tumor
cells to BAEC monolayers resulted in increased numbers of
labeledBAEC (Table II ; and Figs . 2 and 3) ; and (e) BCECF-
labeled tumor cells were unable to transfer their cytoplasmic
dye to communication-deficient MDCK monolayers and,
thus, did not lose any fluorescence over a 3-h co-culture
period with these control cells .
Cytoplasmic dye transfer between B16-FlO melanoma
cells (or R3230AC-MET) and BAEC monolayers was in-
hibited by the addition of 3.5mM of 1-heptanol into the cul-
turemedium (Fig . 4) . The classic inhibitor ofgap junctional
communication impeded the transfer ofBCECF from meta-
static tumor cells to endothelial cells by 70-80% . This finding
strongly suggests that dye transfer between tumor cells and
endothelial cells was achieved by gap junctional channels
and was thus limited to molecules of less than 1,000 daltons
in molecular weight (13) .
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Figure 2. BCECF transfer from labeled B16-FlO (b-d) or B16-FO
(f --h) to unlabeled BAEC monolayers during a coculture period of
1 h : endothelial cell monolayers (4.5 x 105 cells) are seeded with
(a) no tumor cells, (b) 6.25 x 104 , (c) 1.25 x 103 , (d) 2.5 x 105
BCECF-labeled B16-FIO melanoma cells ; (e) no tumor cells, (f)
6.25 x 104, (g) 1.25 x 105 , and (h) 2.5 x 10 5 BCECF-labeled
B16-FO melanoma cells . The number of BAEC to which dye is
transferred increases parallel with the number of BCECF-labeled
B16-F10 melanoma cells seeded onto the endothelial cell mono-
layers . In contrast, increasing numbers of BCECF-labeled B16-FO
cells seeded onto unlabeledBAEC monolayer yielded no significant
increase in the numbers of labeled BAEC.
Cytoplasmic dye transfer between metastatic tumor cells
and BAEC monolayers was bidirectional . When unlabeled
metastatic B16 melanoma cells were added to BCECF la-
beled BAEC monolayers a generalized low level increase in
fluorescence was observed in all adherent tumor cells (Fig .
5) . No dye transfer was observed between control BCECF-
labeled MDCK monolayers and tumor cells during a cocul-
lure period of 3 h .
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Time
Percent BAEC-labeled
BAEC
Tumor cells
fluorescence'
(min)
0 - 141 .4 t 1 .9
15 39.4 122 .5 f 2.0
30 42.4 114.6 f 2 .1
60 50 .3 107 .4 f 2.3Table 11 . BCECF Transfer from B16Melanoma Cells to
BAECMonolayers as a Function oftheNumber ofLabeled
Tumor Cells Added
Indicated numbers of BCECF-labeled B16-FIO or B16-FO melanoma cells
were added to BAEC monolayers as described earlier. After 60 min of cocul-
ture, cells were released from the growth surface, and incubated with mAb
directed against a BAEC-specific surface epitope for 20 min . The cells are then
washed and a second antibody (Goat anti-mouse IgG) conjugated to biotin is
added and incubated for 20 min. The cell suspension is then incubated with
avidin-Phycoerythrin conjugate and analyzed by FACS for both fluorescent
dyes .
Mean t SD
Figure 3 . BCECF transfer from labeled high lung metastatic
R3230AC-METor non-metastatic R3230AC-LR carcinoma cells to
BAEC monolayers during a cocultum period of 1 h : (a) unstained
BAEC, no tumor cells; (b and c) Transfer of BCECF from 3.2 x
10 5 (b) or6.4 x 105 (c) labeledR3230AC-LR to unlabeledBAEC ;
(d)BAEC stainedwith monospecificantibody (PE positive); (e and
f) transfer ofBCECF from labeled 2.1 x 105 (e) or 4.2 x 105 (f)
R3230AC-MET to unlabeled BAEC . The percentage of BCECF-
labeledBAEC andmeanBCECFfluorescence intensity was: (a) no
BCECF fluorescence ; (b) 3.0%, 12.6 t 1.8 ; (c)6.1%, 15.5 t 1.8 ;
(d) 3.2%, 10.0 t 1.5 ; (e) 32%, 28.3 t 1.9 ; and (f) 47%, 44.4
t 1.9.
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Expression ofConnexin43 mRNA
Both low-metastatic B16-FO and high-metastatic B16-F10
melanoma cells contained message for the gap junctional
proteinConnexin43, as determined by Northern blot analysis
with a cDNA probe that contained -65% of the carboxy-
terminal coding region of rat heart Connexin43 (Fig . 6) . This
message is expressed in two mRNA species, the conven-
tional 3-kb band and an as yet unidentified -9-kb band .
Densitometric comparison of the 2 mRNA species between
B16-FO and B16-F10 yielded a three to four fold higher ex-
pression ofthe 3-kb RNA anda two- to threefold higher ex-
pression ofthe9-kbmRNA in B16-F10melanoma cells . This
difference in Connexin43 messagebetweenthelow- andhigh-
metastatic B16 variants . is consistent with their ability to
transfer cytoplasmic dye to BAEC monolayers.
Discussion
Adhesion of blood-bome tumor cells to vascular endothelial
cells isaprerequisite fortumorcellextravasationandthe for-
mation of metastatic tumor colonies . Although the mecha-
nismsby which tumor cells penetrate theendothelial cell lin-
ing have been associated with exposure of subendothelial
matrix (10, 21, 22,40), tumor cell adhesion, and destruction
of basement membrane (26, 27, 29), and tumor cell migra-
tion (46), the initial steps ofextravasation that follow tumor
cell adhesion to the endothelium lining remain largely ob-
scure . Morphological studies on tumor cell/endothelial cell
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Figure4 .BCECFtransferfrom
labeled B16-F10 melanoma
cells toBAEC monolayers dur-
ing a cocultum period of 1 h:
(a)BAEC, labeled without en-
dothelial cell-specific mAb
conjugated with phycoerythrin;
(b)BAEC, labeled withthe en-
dothelial cell-specific mAb
conjugated with phycoeryth-
rin; (c) Transfer of BCECF
from labeled B16-F10 cells
(2.0 X 105) to unlabeled
BAEC ; (d) transfer ofBCECF
from labeled B16-F10 cells
(2.0 x 105) to BAEC in the
presence of 3.5 mM 1-hepta-
nol . The percentage ofBAEC
to which BCECF was trans-
ferred was27.6% (c)and6.0%
(d), indicating that 1-heptanol
inhibits BCECF transfer by
-80% .
Number of tumor
cells added
A B16-FIO
Percent BAEC positive for
BCECF and PE Fluor .
BCECF"
fluorescence
PE'
fluorescence
- 2.2 20.0 t 1 .5 8.6 t 1.6
6.25 x 10 4 2.4 22.0 t 1.5 9.0 f 1.6
1 .25 x 105 32.3 40.2t1.6 7.8f1.7
1 .875 x 105 40.7 51 .7 t 1.6 6.6 t 1.8
B B16-FO
- 2.3 20.0 f 1 .5 8.6 t 1.6
6.25 x 104 2.5 18.9 t 1 .5 10.9 t 2 .0
1 .25 x 105 10.4 27.8 t 1 .5 7.8 t 1 .7
1 .875 x 105 8.9 33.6 t 1 .6 7.0 1.8adhesion indicate that adhesion preferentially occurs at the
apposition zone between neighboring endothelial cells (10,
35), and is followed by the retraction of endothelial cells and
the recanalization ofthe blood vessel around the arrested tu-
mor cell (21, 23) . In this report, we show that an important
event follows adhesion and precedes endothelial retraction
that has not been recognized before. Using fluorescence im-
aging and flow cytometry techniques, we show here that
highly metastatic tumor cells immediately upon adhesion to
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Figure5. BCECF transfer from
labeled BAEC to B16-FlO
cells during a coculture period
of 1 h : (a) BCECF-labeled
BAEC ; (b) unlabeled B16-F10
melanoma cells ; (c) transfer
from BCECFlabeled BAEC
to unlabeled B16-F10 melano-
ma cells (T) ; (d) same as c in
thepresence of3.5 mM 1-hep-
tanol (seetext fordescription) .
The ratio ofBAEC to B16-F10
melanoma cells was 1:1(5 .0 x
10 3 cells) . The percent B16-
1710 labeled by the transfer of
BCECF from labeled BAEC
was -40% and was inhibited
by 1-heptanol .
Figure 6. Northern blot anal-
ysis of B16 total RNA with a
connexin43 cDNA probe (see
text) : both B16-FO (lane 1)
and B16-FlO (lane 2) express
two connexin43 mRNA spe-
cies, a 3- anda 9-kb band . The
3- and 9-kb bands are signifi-
cantly stronger in B1ó-F10.
The positions of the 18S and
28S ribosomal RNA subunits
are identifiedontheright-hand
side of the blot . Each lane
contains 10 pg of total RNA .
the endothelium establish gap junctional channels between
the cytoplasms of tumor cells and endothelial cells . This is
verified by the transfer of a membrane impermeable cyto-
plasmic dye BCECF from tumor cells to endothelial cells.
This dye transfer can be mediated by any of three mecha-
nisms : (a) the formation ofmembrane channels between en-
dothelial cells and adherent tumor cells (gap junctionlike
channels) (13) ; (b) heterotypic cell fusion between tumor
cell and endothelial cell ; and (c) the transfer of tumor cell
membrane vesicles to endothelial cells . The inhibition ofdye
transfer by alkanols (e.g., 1-heptanol), the failure ofMDCK
cells to acquire dye from B16 melanoma cells or R3230AC-
MET carcinoma cells under high density culture conditions
(36), as well as the absence of fluorescein tumor cell vesicles
in the culture media and of endothelial cell-tumor cell fu-
sions, strongly argue for the hypothesis that gap junctional
channels are involved in the transfer of dye from the highly
metastatic tumor cells to the endothelial cells. This conclu-
sion is further supportedby the ability ofBAEC to synthesize
the gap junctional protein connexin43 (24) and our finding
that the communication-efficient cell types used in this study
(e.g ., BAEC [25], B16-F10, B16-F0, and R3230AC-MET)
express mRNA for connexin43. Interestingly, the connexin43
message is present in higher amounts in highly metastatic tu-
mor cells than in low metastatic cells .
The fact that dye transfer precedes extravasation and is
far more pronounced in highly metastatic B16-FIO and
R3230AC-MET than in low metastatic B16-FO and is absent
in non-metastatic R3230AC-LR implies that metabolic
couplingmay play an important role in tumor cell extravasa-
tion . For example, low-molecular weight components syn-
thesized by tumor cells could be transferred to endothelium
without risking the dilution to inactive concentrations in the
blood to initiate locally confined retraction of endothelial
cells from their basement membrane, thereby allowing tu-
mor cells to adhere to subendothelial matrix and to extrava-
sate. A candidate molecule for such action is the arachidonic
acid metabolite 12(S)-HETE, which has been shown not
only to induce endothelial cell retraction in vitro, but also
to be synthesized in increased amounts by highly metastatic
tumor cells (15, 17) . Beyond mediating retraction, the estab-
lishment of gap junctionlike channels between tumor cells
and endothelium may induce, by as yet unknown signaling
events, other endothelial cell responses known to be as-
sociated with extravasation . One such effect may be the di-
rect stimulation of endothelial cells by the adherent tumor
cell to induce lysis of its basement membrane . Although
degradation of basement membrane has been associated
unilaterally with a tumor cell function (27, 29, 30), it is con-
ceivable that endothelial cells which have beenshown to syn-
thesize basement membrane-degrading proteolytic enzymes
(14, 19), may have amore active role in basement membrane
degradation than is generally ascribed to them . By signal
transfer from tumor cells, endothelial cells may be stimu-
lated to synthesize and/or secrete increased amounts ofbase-
ment membrane-degrading enzymes and, thus, actively par-
ticipate in tumor cell extravasation. Although this hypothesis
is speculative and is currently under investigation in our lab-
oratory, it is attractive as it once more represents a locally
confined effect that is restricted to the endothelial cell to
which the tumor cell adheres and communicates with .
The importance of cell-cell communication in tumor cell
1380extravasation is further substantiated by three observations.
Firstly, Bráunder and Hulser (7), using an in vitro invasion
assay developed by Mareel et al. (28) have shown that only
tumor cells which are able to communicate with cells of
chick embryo heart fragments are able to invade this tissue,
while tumor cells which are unable to do so form a cellular
capsule around the heart fragments. Secondly, low meta-
static tumor cells transfer cytoplasmic dye to endothelium
to a significantly lesser extentthan their highly metastatic
counterparts. Thirdly, heterotypic coupling is also observed
between lymphocytes and cndothelial cells (16). During
theirhoming to selective lymphoid tissues, lymphocytes use
many ofthe same steps as blood-borne cancer cellsdo during
the colonization of secondary organs. Arrest of lymphocytes
in lymphoid tissues is initiated by the recognition of specific
adhesion molecules expressed on the surface of high endo-
thelial venules and is followed by the extravasation of the
lymphocyte from the venular lumen into the lymphoid tissue
(8, 38, 39) . Since extravasation of lymphocytes is similar in
nature to that of tumor cells, it is only logical that they may
be governed by similar mechanisms. Gapjunction formation
may therefore be a key event in the initiation ofextravasation,
and the ability to communicate with the endothelium may
represent a critical characteristic of successfully metastatic
tumor cells.
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